Berkshire Partners' Affordable Care scores a valuation of some $2.7bn as technology adoption, future M&A opportunities and a large and growing tooth replacement market present a favorable backdrop for the specialist DSO.
Grattan brings vast software investing experience from THL, where she was involved with deals including Nextech, Alfresco Software, iHeartMedia, Juvare, inVentiv Health, Univision Communications, and West Corporation.
Novo Holdings’ investment in BBI is part of its Principal Investments strategy targeting investments in well-established life science companies with leading positions in attractive market segments and strong underlying growth drivers.
Accelmed looks to stand out by investing in US-based HealthTech companies that are unlikely to appeal to the traditional private equity fund, taking advantage of its Israel-based team that sources add-ons.
Puerto Rico-based MCS is the 14th largest Medicare Advantage plan and the 7th largest dual-eligible plan in the United States, servicing more than 185,000 Medicare Advantage members and 205,000 Commercial members.
The leadership expansion comes after Accelmed's 2nd fund closed at its hard cap of $400 million earlier this year, and amid recent investments in TearLab, NeuroPace (which recently went public) and MedMinder.